Stockhub

Pivotal Therapeutics Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 September 2022

  • curprev 21:3421:34, 23 September 2022 95.149.241.133 talk 1,086 bytes +1,086 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels...."
Retrieved from "https://stockhub.co/research/Pivotal_Therapeutics_Inc."